{
  "id": "04277c460e09bc93",
  "title": "Novartis Ianalumab Receives Fda Breakthrough Therapy Designation for Sjogren Disease",
  "description": "20260116T181500Z",
  "content": "",
  "source": "marketscreener.com",
  "source_url": "https://www.marketscreener.com/news/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-for-sjogren-s-disease-ce7e58dfd980f02d",
  "published_at": "20260116T181500Z",
  "fetched_at": "2026-01-17T00:22:29.333379+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "",
  "raw_data": {
    "url": "https://www.marketscreener.com/news/novartis-ianalumab-receives-fda-breakthrough-therapy-designation-for-sjogren-s-disease-ce7e58dfd980f02d",
    "url_mobile": "",
    "title": "Novartis Ianalumab Receives Fda Breakthrough Therapy Designation for Sjogren Disease",
    "seendate": "20260116T181500Z",
    "socialimage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
    "domain": "marketscreener.com",
    "language": "English",
    "sourcecountry": ""
  }
}